BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16886919)

  • 1. Interferon-alpha therapy in HBeAg-negative chronic hepatitis B: a long-term prospective study from north-western Greece.
    Baltayiannis G; Katsanos K; Karayiannis P; Tsianos EV
    Aliment Pharmacol Ther; 2006 Aug; 24(3):525-33. PubMed ID: 16886919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study of the relapse of patients with chronic hepatitis B undergoing first and repeated recombinant interferon-alpha therapy during long-term follow up].
    Liu DL; Luo KX; Feng XR; Fu QX; Hou JL
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(26):1840-3. PubMed ID: 17922996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B.
    van Zonneveld M; Honkoop P; Hansen BE; Niesters HG; Darwish Murad S; de Man RA; Schalm SW; Janssen HL
    Hepatology; 2004 Mar; 39(3):804-10. PubMed ID: 14999700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of interferon-alpha therapy for HBeAg-negative chronic hepatitis B and its influencing factors].
    Mao QG; Luo KX; Fu QF; Feng XR; Guo YB; Zhu YF; Peng J; Hou JJ
    Zhonghua Gan Zang Bing Za Zhi; 2004 Oct; 12(10):582-4. PubMed ID: 15504285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of lamivudine treatment in patients with severe acute exacerbation of hepatitis B e antigen (HBeAg)-positive chronic hepatitis B.
    Wong VW; Wong GL; Tsang SW; Hui AY; Chim AM; Yiu KK; Chan HY; Chan FK; Sung JJ; Chan HL
    Antivir Ther; 2008; 13(4):571-9. PubMed ID: 18672536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High doses of alpha-interferon are required in chronic hepatitis due to coinfection with hepatitis B virus and hepatitis C virus: long term results of a prospective randomized trial.
    Villa E; Grottola A; Buttafoco P; Colantoni A; Bagni A; Ferretti I; Cremonini C; Bertani H; Manenti F
    Am J Gastroenterol; 2001 Oct; 96(10):2973-7. PubMed ID: 11693335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter retrospective study of response to interferon in chronic hepatitis B.
    Martín-Vivaldi R; Nogueras F; Vignote ML; Salmerón J; Aguilar J; Romero M; Andrade R; De la Mata M; Moreno JM; Pérez J; García G; López de Hierro M; Gómez F; Palacios A; Otero S; Suárez E; Poyatos A; Quintero D
    Rev Esp Enferm Dig; 2000 Sep; 92(9):561-72. PubMed ID: 11138238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of interferon and lamivudine treatment in Japanese patients with HBeAg positive chronic hepatitis B.
    Arase Y; Ikeda K; Suzuki F; Suzuki Y; Kobayashi M; Akuta N; Hosaka T; Sezaki H; Yatsuji H; Kawamura Y; Kobayashi M; Kumada H
    J Med Virol; 2007 Sep; 79(9):1286-92. PubMed ID: 17607775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to interferon-alpha in chronic hepatitis B patients with and without precore mutant strain and effects on HBsAg titers.
    Akhan SC; Yulugkural Z; Vahaboglu H
    Chemotherapy; 2007; 53(6):402-6. PubMed ID: 17934260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome in children with chronic hepatitis B: a 24-year observation period.
    Iorio R; Giannattasio A; Cirillo F; D' Alessandro L; Vegnente A
    Clin Infect Dis; 2007 Oct; 45(8):943-9. PubMed ID: 17879906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Withdrawal of lamivudine in HBeAg-positive chronic hepatitis B patients after achieving effective maintained virological suppression.
    Yeh CT; Hsu CW; Chen YC; Liaw YF
    J Clin Virol; 2009 Jun; 45(2):114-8. PubMed ID: 19451024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term therapeutic efficacy of lamivudine compared with interferon-alpha in children with chronic hepatitis B: the younger the better.
    Choe BH; Lee JH; Jang YC; Jang CH; Oh KW; Kwon S; Hyun MC; Ko CW; Lee KS; Lee WK
    J Pediatr Gastroenterol Nutr; 2007 Jan; 44(1):92-8. PubMed ID: 17204960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early response to lamivudine therapy in clinically non-cirrhotic chronic hepatitis B patients with decompensation.
    Dai CY; Yu ML; Hsieh MY; Lee LP; Hou NJ; Huang JF; Chen SC; Lin ZY; Hsieh MY; Wang LY; Tsai JF; Chang WY; Chuang WL
    Liver Int; 2007 Dec; 27(10):1364-70. PubMed ID: 17900250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration of an association between detection of IgG antibody reactivity towards the C-terminal region of the preS1 protein of hepatitis B virus and the capacity to respond to interferon therapy in chronic hepatitis B.
    Hellström U; Lindh M; Krogsgaard K; Sylvan S
    J Gastroenterol Hepatol; 2008 May; 23(5):804-10. PubMed ID: 17931371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tailored regimen of interferon alpha for HBeAg-positive chronic hepatitis B: a prospective controlled study.
    Luo K; Mao Q; Karayiannis P; Liu D; Liu Z; Zhou Y; Feng X; Zhu Y; Guo Y; Jiang R; Zhou F; Peng J; Hou J
    J Viral Hepat; 2008 Sep; 15(9):684-9. PubMed ID: 18554243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of chronic hepatitis B virus infection - Dutch national guidelines.
    Buster EH; van Erpecum KJ; Schalm SW; Zaaijer HL; Brouwer JT; Gelderblom HC; de Knegt RJ; Minke Bakker C; Reesink HW; Janssen HL;
    Neth J Med; 2008; 66(7):292-306. PubMed ID: 18663260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained virological response to interferon reduces cirrhosis in chronic hepatitis C: a 1,386-patient study from Taiwan.
    Huang JF; Yu ML; Lee CM; Dai CY; Hou NJ; Hsieh MY; Wang JH; Lu SN; Sheen IS; Lin SM; Chuang WL; Liaw YF
    Aliment Pharmacol Ther; 2007 May; 25(9):1029-37. PubMed ID: 17439503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term lamivudine therapy in HBeAg-negative chronic active hepatitis B in Taiwan.
    Chien RN; Liaw YF
    Antivir Ther; 2006; 11(7):947-52. PubMed ID: 17302259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing outcome of lamivudine in anti-HBe-positive chronic hepatitis B.
    Ascione A; Ascione T; Lanza AG; Utech W; Di Costanzo GG; Macri M
    Hepatogastroenterology; 2006; 53(72):919-23. PubMed ID: 17153453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-year lamivudine treatment for hepatitis B e antigen-negative chronic hepatitis B: a double-blind, placebo-controlled trial.
    Chan HL; Wang H; Niu J; Chim AM; Sung JJ
    Antivir Ther; 2007; 12(3):345-53. PubMed ID: 17591024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.